Publications 2024
Contribution of major histocompatibility complex class II immunostaining in distinguishing idiopathic inflammatory myopathy subgroups: A histopathological cohort study
Lessard LER, Robert M, Fenouil T, Mounier R, Landel V, Carlesimo M, Hot A, Chazaud B, Laumonier T, Streichenberger N, Gallay L.
J Neuropathol Exp Neurol. 2024 Sep 16:nlae098. doi: 10.1093/jnen/nlae098
Factors Associated with Fatigue in COVID-19 ICU Survivors
Kennouche D, Foschia C, Brownstein CG, Lapole T, Rimaud D, Royer N, LE Mat F, Thiery G, Gauthier V, Giraux P, Oujamaa L, Sorg M, Verges S, Doutreleau S, Marillier M, Prudent M, Bitker L, Féasson L, Gergelé L, Stauffer E, Guichon C, Gondin J, Morel J, Millet GY.
Med Sci Sports Exerc. 2024 Sep 1;56(9):1563-1573. doi: 10.1249/MSS.0000000000003455
Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments
Espino-Gonzalez E, Dalbram E, Mounier R, Gondin J, Farup J, Jessen N, Treebak JT.
Cell Metab. 2024 Jun 4;36(6):1204-1236. doi: 10.1016/j.cmet.2024.02.014.
Measurement of Myonuclear Accretion In Vitro and In Vivo
Lessard L, Saugues A, Gondin J, Mounier R, Kneppers A.
Tirasemtiv enhances submaximal muscle tension in an Acta1:p.Asp286Gly mouse model of nemaline myopathy
Galli RA, Borsboom TC, Gineste C, Brocca L, Rossi M, Hwee DT, Malik FI, Bottinelli R, Gondin J, Pellegrino MA, de Winter JM, Ottenheijm CAC.
J Gen Physiol. 2024 Apr 1;156(4):e202313471. doi: 10.1085/jgp.202313471.
Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia
Pilotto F., M Chellapandi D., Puccio H.
Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?
Pilotto F., Del Bondio A., Puccio H.
Skeletal muscle niche, at the crossroad of cell/cell communications.
Theret M, Chazaud B.
Curr Top Dev Biol. 2024 158:203-220. doi: 10.1016/bs.ctdb.2024.01.012